RECIST and iRECIST Comparison in a Cohort of Patients with Advanced NSCLC Treated with Immunotherapy: Preliminary Study

被引：0
|
作者：
Garcia Martinez, F. [1 ]
Fernandez-Velilla Pena, M. [2 ]
Cruz Castellanos, P. [1 ]
De Castro Carpeno, J. [1 ]
Pertejo, A. [1 ]
Torres Sanchez, I. [1 ]
机构：
[1] Hosp Univ La Paz, Radiodiagnost, Madrid, Spain
[2] Hosp Univ La Paz, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Immunotherapy; RECIST; iRECIST;
D O I：
10.1016/j.jtho.2019.08.2152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP1.04-30
引用
收藏
页码：S980 / S980
页数：1
相关论文
共 50 条
  • [1] Comparison of RECIST and iRECIST criteria in patients with advanced lung cancer treated with nivolumab
    Singla, Rishu
    Jajodia, Ankush
    Agrawal, R. K.
    Rao, Avinash
    Pasricha, Sunil
    Batra, Ullas
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1212 - 1218
  • [2] Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
    Ahmed, Firas S.
    Dercle, Laurent
    Goldmacher, Gregory V.
    Yang, Hao
    Connors, Dana
    Tang, Ying
    Karovic, Sanja
    Zhao, Binsheng
    Carvajal, Richard D.
    Robert, Caroline
    Maitland, Michael L.
    Oxnard, Geoffrey R.
    Schwartz, Lawrence H.
    EUROPEAN RADIOLOGY, 2021, 31 (04) : 1853 - 1862
  • [3] Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial
    Firas S. Ahmed
    Laurent Dercle
    Gregory V. Goldmacher
    Hao Yang
    Dana Connors
    Ying Tang
    Sanja Karovic
    Binsheng Zhao
    Richard D. Carvajal
    Caroline Robert
    Michael L. Maitland
    Geoffrey R. Oxnard
    Lawrence H. Schwartz
    European Radiology, 2021, 31 : 1853 - 1862
  • [4] Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab
    Fukuokaya, Wataru
    Kimura, Takahiro
    Yanagisawa, Takafumi
    Kimura, Shoji
    Tsuzuki, Shunsuke
    Koike, Yuhei
    Iwamoto, Yuya
    Enei, Yuki
    Tanaka, Masatoshi
    Urabe, Fumihiko
    Onuma, Hajime
    Honda, Mariko
    Miki, Jun
    Oyama, Yu
    Abe, Hirokazu
    Egawa, Shin
    BJU INTERNATIONAL, 2021, 127 (01) : 90 - 95
  • [5] Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Park, Hyo Jung
    Kim, Gun Ha
    Kim, Kyung Won
    Lee, Choong Wook
    Yoon, Shinkyo
    Chae, Young Kwang
    Tirumani, Sree Harsha
    Ramaiya, Nikhil H.
    CANCERS, 2021, 13 (01)
  • [6] RECIST 1.1 in NSCLC Patients With EGFR Mutations Treated With EGFR Tyrosine Kinase Inhibitors: Comparison With RECIST 1.0
    Nishino, Mizuki
    Cardarella, Stephanie
    Jackman, David M.
    Ramaiya, Nikhil H.
    Rabin, Michael S.
    Hatabu, Hiroto
    Jaenne, Pasi A.
    Johnson, Bruce E.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2013, 201 (01) : W64 - W71
  • [7] Improved Survival of Elderly Patients with NSCLC Treated in the Immunotherapy Era: A Historical Cohort Study
    Pelizzari, G.
    Targato, G.
    Corvaja, C.
    Fantin, A.
    De Maglio, G.
    Rossetto, C.
    Rizzato, S.
    Fasola, G.
    Follador, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S998 - S999
  • [8] Effect of Early Steroids use in Advanced NSCLC Patients Treated with Immunotherapy
    Fuca, G.
    Poggi, M.
    Galli, G.
    Imbimbo, M.
    Lo Russo, G.
    Proto, C.
    Vitali, M.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Signorelli, D.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S390 - S390
  • [9] Prognostic value of PIOS (Patras Immunotherapy Score) model in patients with advanced NSCLC treated with combination of immunotherapy with chemotherapy: Preliminary results from a European retrospective study.
    Dimtrakopoulos, Foteinos-Ioannis D.
    Christopoulos, Petros
    Elshiaty, Mariam
    Daniello, Lea
    Pyrousis, Ioannis
    Kottorou, Anastasia E.
    Makatsoris, Thomas
    Kalofonos, Haralabos
    Koutras, Angelos
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Early Change of dNLR Is Correlated with Outcomes in Advanced NSCLC Patients Treated with Immunotherapy
    Mezquita, L.
    Preeshagul, I.
    Auclin, E.
    Saravia, D.
    Hendriks, L.
    Rizvi, H.
    Planchard, D.
    Park, W.
    Nadal, E.
    Ruffinelli, J. C.
    Ponce, S.
    Audigier-Valette, C.
    Carnio, S.
    Novello, S.
    Zalcman, G.
    Majem, M.
    Mariniello, A.
    Dingemans, A. M.
    Lopes, G.
    Rossoni, C.
    Pignon, J.
    Chaput, N.
    Hellmann, M.
    Arbour, K.
    Besse, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S273 - S273
12345